Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Caitlin E. Cox

October 03, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2025

Caitlin E. Cox

July 31, 2025

News Daily News

FDA Updates CV Warnings Around COVID-19 mRNA Vaccines

Michael O'Riordan

June 26, 2025

News Conference News ACC 2023

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Caitlin E. Cox

March 14, 2023

News Daily News

Acute Cardiac Events More Common in COVID-19 Patients With Heart Histories

Caitlin E. Cox

February 10, 2023

News Daily News

Heart Risks Higher With Moderna vs Pfizer/BioNTech Shot, Direct Comparison Shows

Caitlin E. Cox

November 09, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News Daily News

Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19

Michael O'Riordan

July 20, 2022

News Daily News

Even Less-Severe COVID-19 Can Have Long-term CV Effects

Caitlin E. Cox

February 10, 2022

News Daily News

New Insights Into Myocarditis and mRNA COVID-19 Vaccines

Yael L. Maxwell

December 17, 2021

News Conference News TCT 2021

Myocarditis After COVID-19 Vaccine: Data ‘Reassure’ More and More

Todd Neale

November 04, 2021

News Daily News

No Long-term CV Impact With Mild COVID-19, Two New Studies Reassure

L.A. McKeown

May 12, 2021

News Daily News

Low Incidence of Myocarditis Among Pro Athletes Diagnosed With COVID-19

Michael O'Riordan

March 05, 2021

News Daily News

Colchicine in the Crosshairs for Its High US Cost

Caitlin E. Cox

December 01, 2020

News Daily News

Influenza and Acute CV Events Can Go Hand in Hand

Caitlin E. Cox

August 25, 2020

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

Advertisement

ACC: It’s Time for Clinicians to Address Inflammation in CVD

TCTMD’s Top 10 Most Popular Stories for July 2025

FDA Updates CV Warnings Around COVID-19 mRNA Vaccines

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Acute Cardiac Events More Common in COVID-19 Patients With Heart Histories

Heart Risks Higher With Moderna vs Pfizer/BioNTech Shot, Direct Comparison Shows

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19

Even Less-Severe COVID-19 Can Have Long-term CV Effects

New Insights Into Myocarditis and mRNA COVID-19 Vaccines

Myocarditis After COVID-19 Vaccine: Data ‘Reassure’ More and More

No Long-term CV Impact With Mild COVID-19, Two New Studies Reassure

Low Incidence of Myocarditis Among Pro Athletes Diagnosed With COVID-19

Colchicine in the Crosshairs for Its High US Cost

Influenza and Acute CV Events Can Go Hand in Hand

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content